...
首页> 外文期刊>Arthritis Research >Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation
【24h】

Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation

机译:人成纤维细胞中11β-羟类固醇脱氢酶1型的差异表达,功能和对炎症刺激的反应:炎症的组织特异性调节机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Stromal cells such as fibroblasts play an important role in defining tissue-specific responses during the resolution of inflammation. We hypothesized that this involves tissue-specific regulation of glucocorticoids, mediated via differential regulation of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Expression, activity and function of 11β-HSD1 was assessed in matched fibroblasts derived from various tissues (synovium, bone marrow and skin) obtained from patients with rheumatoid arthritis or osteoarthritis. 11β-HSD1 was expressed in fibroblasts from all tissues but mRNA levels and enzyme activity were higher in synovial fibroblasts (2-fold and 13-fold higher mRNA levels in dermal and synovial fibroblasts, respectively, relative to bone marrow). Expression and activity of the enzyme increased in all fibroblasts following treatment with tumour necrosis factor-α or IL-1β (bone marrow: 8-fold and 37-fold, respectively, compared to vehicle; dermal fibroblasts: 4-fold and 14-fold; synovial fibroblasts: 7-fold and 31-fold; all P < 0.01 compared with vehicle). Treatment with IL-4 or interferon-γ was without effect, and there was no difference in 11β-HSD1 expression between fibroblasts (from any site) obtained from patients with rheumatoid arthritis or osteoarthritis. In the presence of 100 nmol/l cortisone, IL-6 production – a characteristic feature of synovial derived fibroblasts – was significantly reduced in synovial but not dermal or bone marrow fibroblasts. This was prevented by co-treatment with an 11β-HSD inhibitor, emphasizing the potential for autocrine activation of glucocorticoids in synovial fibroblasts. These data indicate that differences in fibroblast-derived glucocorticoid production (via the enzyme 11β-HSD1) between cells from distinct anatomical locations may play a key role in the predeliction of certain tissues to develop persistent inflammation.
机译:基质细胞(如成纤维细胞)在炎症消退过程中定义组织特异性反应中起重要作用。我们假设这涉及糖皮质激素的组织特异性调节,该调节是通过酶11β-羟类固醇脱氢酶1型(11β-HSD1)的差异调节介导的。在来自类风湿性关节炎或骨关节炎患者的各种组织(滑膜,骨髓和皮肤)的匹配成纤维细胞中评估了11β-HSD1的表达,活性和功能。 11β-HSD1在所有组织的成纤维细胞中表达,但滑膜成纤维细胞的mRNA水平和酶活性较高(相对于骨髓而言,真皮和滑膜成纤维细胞的mRNA水平分别高2倍和13倍)。肿瘤坏死因子-α或IL-1β处理后,所有成纤维细胞中酶的表达和活性均增加(与媒介物相比,骨髓分别为8倍和37倍;真皮成纤维细胞:4倍和14倍;滑膜成纤维细胞:7倍和31倍;与溶媒相比,所有P <0.01)。用IL-4或干扰素-γ治疗无效,并且从类风湿关节炎或骨关节炎患者获得的成纤维细胞(来自任何部位)的11β-HSD1表达没有差异。在存在100 nmol / l可的松的情况下,滑膜来源的成纤维细胞的特征性IL-6产生在滑膜中显着降低,而真皮或骨髓成纤维细胞则没有。通过与11β-HSD抑制剂共同治疗可防止这种情况,强调滑膜成纤维细胞中糖皮质激素的自分泌激活潜力。这些数据表明,来自不同解剖位置的细胞之间成纤维细胞衍生的糖皮质激素产生的差异(通过11β-HSD1酶)可能在某些组织发生持续炎症的预测中起关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号